Plasma levels of soluble E-cadherin and the keratinocytes growth factor in intrauterine growth restriction


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Aim. To investigate plasma levels of soluble E-cadherin (sE-cad) and the keratinocytes growth factor (KGF) in women with fetal growth restriction (FGR). Materials and methods. The study included 25pregnant women with fetal growth restriction and 19 women with a healthy pregnancy. Plasma levels of sE-cad and KGF were determined by ELISA. Results. In women with FGR, the plasma level of sE-cad was decreased (p=0.006), while the KGF level was increased (p=0.037). ROC analysis assessing the diagnostic accuracy of sE-cad and KGF showed the AUC of 0.74 and 0.69, respectively. A low plasma level of sE-cad in women with FGR reflects impaired mobility and proliferative activity of trophoblast cells. In growth-restricted pregnancy, higher levels of KGF, as a proliferation factor, may be associated with the activation of compensatory mechanisms aimed to improve trophoblast cell proliferation. Conclusion. Plasma levels of sE-cad and KGF in pregnant women reflect the underlying pathological process interfering with the healthy growth of the placenta and may, therefore, be used as markers offetal growth restriction.

全文:

受限制的访问

作者简介

Aleksey Krasnyi

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: alexred@list.ru
Ph.D. (bio.sci.), Head of the Cytology Laboratory

Anuta Khachaturyan

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: x.anyt37@mail.ru
Ph.D. Student

Valentina Vtorushina

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: v_vtorushina@oparina4.ru
Ph.D., Laboratory Physician at the Laboratory of Clinical Immunology

Lubov Krechetova

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: l_krechetova@oparina4.ru
PhD, MD(Medicine), Head of the laboratory of clinical immunology

Natalia Kan

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia; European Medical Center

Email: kan-med@mail.ru
Dr.Med.Sci., Head Physician of the Perinatal Center of European Medical Center, Professor at the Department of Obstetrics and Gynecology

Victor Tyutyunnik

European Medical Center

Email: tioutiounnik@mail.ru
Dr.Med.Sci., Deputy Head Physician

参考

  1. Стрижаков А.Н., Игнатко И.В., Тимохина Е.В., Белоцерковцева Л.Д. Синдром задержки роста плода. Патогенез. Диагностика. Лечение. Акушерская тактика. М.: ГЭОТАР-Медиа; 2012. 120 с. [Strizhakov A.N., Ignatko I.V., Timohina E.V., Belotserkovtseva L.D. Fetal growth retardation. Pathogenesis. Diagnostics. Treatment. Obstetric tactics. Moscow: GEOTAR-Media; 2012. 120 р. (in Russian)].
  2. Unterscheider J., Daly S., Geary M.P., Kennelly M.M., McAuliffe F.M., ODonoghue K. et al. Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study. Am. J. Obstet. Gynecol. 2013; 208(4): 290. e1-6. https://dx.doi.org/10.1016/j.ajog.2013.02.007.
  3. Gardosi J., Madurasinghe V., Williams M., Malik A., Francis A. Maternal and fetal risk factors for stillbirth: population based study. BMJ. 2013; 346: f108. https:// dx.doi.org/10.1136/bmj.f108.
  4. Sharma D., Shastri S., Sharma P. Intrauterine growth restriction: antenatal and postnatal aspects. Clin. Med. Insights Pediatr. 2016; 10: 67-83. https://dx.doi. org/10.4137/CMPed.S40070. eCollection 2016.
  5. Andreadis S.T., Hamoen K.E., Yarmush M.L., Morgan J.R. Keratinocyte growth factor induces hyperproliferation and delays differentiation in a skin equivalent model system. FASEB J. 2001; 15(6): 898-906. https://dx.doi.org/10.1096/ fj.00-0324com.
  6. Najy A.J., Day K.C, Day M.L. The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation. J. Biol. Chem. 2008; 283(26): 18393-401. https://dx.doi.org/10.1074/jbc.M801329200.
  7. Красный А.М., Хачатурян А.А., Кан Н.Е., Хачатрян З.В., Тютюнник В.Л., Волгина Н.Е., Ганичкина М.Б., Мантрова Д.А., Садекова А.А. Роль Е-кадгерина в формировании задержки роста плода. Акушерство и гинекология. 2018; 6: 38-43. [Krasnyi A.M., Khachaturyan A.A., Kan N.E., Khachatryan Z.V., Tyutyunnik V.L., Volgina N.E., Ganichkina M.B., Mantrova D.A., Sadekova A.A. The role E-kadherin in the formation of intrauterine growth restriction. Akusherstvo i ginekologiya / Obstetrics and Gynecology. 2018; (6): 38-43. (in Russian)]. https://dx.doi.org/10.18565/ aig.2018.6.38-43.
  8. Szukiewicz D., Szewczyk G., Watroba M., Kurowska E., Maslinski S. Isolated placental vessel response to vascular endothelial growth factor and placenta growth factor in normal and growth-restricted pregnancy. Gynecol. Obstet. Invest. 2005; 50(2): 102-7. https://dx.doi.org/10.1159/000082622.
  9. Brouxhon S.M., Kyrkanides S., Raja V., Silberfeld A., Teng X., Trochesset D. et al. Ectodomain-specific E-cadherin antibody suppresses skin SCC growth and reduces tumor grade: a multitargeted therapy modulating RTKs and the PTEN-p53-MDM2 axis. Mol. Cancer Ther. 2014; 13(7): 1791-802. https://dx.doi. org/10.1158/1535-7163.MCT-13-0971.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##